Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOrigin Regulatory News (OGN)

Share Price Information for Origin (OGN)

Share Price is delayed by 15 minutes
Get Live Data
365.00    0.00 (0.00%)
Bid:
360.00
Ask:
370.00
Spread: 10.00 (2.778%)
Market Cap: £392.33m
OGN Live PriceLast checked at - London Stock Exchange

Intraday Origin Share Chart

Directorate Update

1 Oct 2018 16:59

RNS Number : 5966C
Origin Enterprises Plc
01 October 2018
 

 

Directorate Update

1 October 2018

 

Origin Enterprises plc ('Origin' or the 'Company') announces the appointment of Sean Coyle (45) to the Board of the Company with effect from today 1 October 2018, as previously outlined in the regulatory announcements of 7 June 2018 and 26 September 2018. Sean was appointed Chief Financial Officer on 1 September 2018.

 

Full details of his current and past directorships within the last five years are outlined below. None of these entities have any relationship with Origin Enterprises plc.

 

There are no other items requiring disclosure in accordance with Schedule 2(g) of the AIM Rules for Companies or the ESM Rules for Companies. Sean Coyle currently has an interest in 7,000 ordinary shares in Origin.

 

Current Directorships

 

None

 

Past Directorships

Sean Gerard Coyle was a director or partner of the following within the last five years:

 

Steel Eagle Holdings, Inc

Dull Investment Corporation

Sharp Clinical Services Incorporated

Sharp Corporation

Ashfield Healthcare Communications, LLC

Ballina Pharma Inc

Magna Healthcare Inc

Ashfield Healthcare LLC

UDG Healthcare Limited

UDG Healthcare UK (Holdco) Limited

Mantis Surgical Limited

Mediscope Limited

Barclay (Northern Ireland) Limited

Klondyke Enterprises Limited

Mansett Limited

Network Hospital Services Limited

Robert Smith & Co. (Derry) Limited

Vector Scientific Limited

Intraveno (N.I.) Limited

New Splint Limited

Unitech Equipment Limited

TD Packaging Limited

Ashfield Alliance Limited

Ashfield Healthcare (Ireland) Limited

Dublin Drug (Investments) Limited

Dublin Drug Company Limited

Dublin Drug Public Limited Company

Dugdale Trading Limited

Marker (U.D.) Ireland Limited

Oremelt Company Unlimited Company

Pharmexx Ireland (Sales Solutions) Limited

UDG Healthcare Ayrtons (Dublin) Limited

UDG Healthcare Finance Limited

UDG Healthcare Ireland Limited

UDG Healthcare Nordic Limited

UDG Healthcare Packaging Group Limited

UDG Healthcare Property Holdings Limited

United Care Limited

Aquilant Analytical Sciences Limited

Aquilant Endoscopy Limited

Aquilant Limited

Aquilant Medical (ROI) Limited

Aquilant Nederland B.V.

Aquilant Northern Ireland Limited

Aquilant Pharmaceuticals Limited

Aquilant Scientific (ROI) Limited

UDG Healthcare Specialist Product Services Limited

Alchem Plc

Pemberton Marketing Limited

Magir Limited

UDG Healthcare Distributors Limited

The Health Insurance Authority

Marker International BV

Magna Finance BV

UniDrug Distribution Group Limited

 

ENDS

 

 

 

 

 

 

Enquiries:

 

Peter Dunne +353 (0)1 563 4965

Company Secretary

Origin Enterprises plc

 

Davy (Nominated Adviser)

Anthony Farrell + 353 (0)1 614 9993

 

 

About Origin Enterprises plc

Origin Enterprises plc is a focused Agri-Services group providing specialist On-Farm Agronomy Services, Digital Agricultural Services and the supply of crop technologies and inputs. The Group has leading market positions in Ireland, the United Kingdom, Belgium, Brazil, Poland, Romania and Ukraine. Origin is listed on the ESM and AIM markets of the Irish and London Stock Exchanges.

 

ESM ticker symbol: OIZ

AIM ticker symbol: OGN

 

Website: www.originenterprises.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STRBUBDGSUGBGIB
Date   Source Headline
6th Jan 20223:33 pmRNSDirector/PDMR Shareholding
3rd Dec 20211:32 pmRNSHolding(s) in Company
25th Nov 20215:03 pmRNSResult of AGM
25th Nov 20217:00 amRNSQ1 Trading Update
19th Nov 20217:00 amRNSUpdate on AGM Arrangements
9th Nov 202112:16 pmRNSHolding(s) in Company
4th Nov 20217:00 amRNSBlock Listing Six Monthly Return
29th Oct 20213:52 pmRNSNotice of AGM
22nd Oct 20217:00 amRNS2021 Annual Report and Sustainability Report
15th Oct 202111:46 amRNSDirectorate Change
13th Oct 20215:04 pmRNSDirector/PDMR Shareholding
12th Oct 20214:30 pmRNSDirector/PDMR Shareholding
8th Oct 20213:59 pmRNSDirector/PDMR Shareholding
29th Sep 20217:00 amRNSPRELIMINARY RESULTS STATEMENT
20th Aug 20217:00 amRNSDirectorate Changes
1st Jul 20217:00 amRNSSale of Belgian fertiliser business
16th Jun 20217:00 amRNSQ3 Trading Update
10th Jun 20215:10 pmRNSHolding(s) in Company
4th May 20217:00 amRNSBlock listing Interim Review
16th Mar 20217:00 amRNSHolding(s) in Company
15th Mar 20219:41 amRNSHolding(s) in Company
10th Mar 20217:00 amRNSMigration of Participating Securities
5th Mar 20217:00 amRNSAcquisition of Greentech Ltd
4th Mar 20217:00 amRNSInterim Results Statement
1st Mar 202110:00 amRNSNotice of Interim Results
28th Jan 202112:53 pmRNSResult of EGM
19th Jan 202111:51 amRNSDirector/PDMR Shareholding
18th Jan 202112:07 pmRNSEGM COVID-19 Mitigation Measures
12th Jan 20219:17 amRNSHolding(s) in Company
24th Dec 202011:38 amRNSNotice of EGM
23rd Dec 202011:40 amRNSDirector/PDMR Shareholding
17th Dec 20207:00 amRNSHolding(s) in Company
1st Dec 20207:00 amRNSConfirmation of Group CFO Commencement Date
18th Nov 20205:07 pmRNSAnnual General Meeting
18th Nov 20207:00 amRNSQ1 Trading Update
13th Nov 20207:00 amRNSHolding(s) in Company
4th Nov 20207:00 amRNSBlock listing Interim Review
30th Oct 20201:45 pmRNSHolding(s) in Company
23rd Oct 20204:34 pmRNSHolding(s) in Company
23rd Oct 202010:51 amRNSPosting of 2020 Annual Report and Notice of AGM
23rd Oct 20209:30 amRNSHolding(s) in Company
23rd Oct 20209:28 amRNSHolding(s) in Company
20th Oct 202011:14 amRNSHolding(s) in Company
19th Oct 20202:00 pmRNSAnnual Report and Accounts 2020
9th Oct 20202:44 pmRNSHolding(s) in Company
1st Oct 20207:00 amRNSAppointment of Non-Executive Director
29th Sep 20204:45 pmRNSDirector/PDMR Shareholding
29th Sep 20204:45 pmRNSDirector/PDMR Shareholding
25th Sep 20207:00 amRNSHolding(s) in Company
23rd Sep 20207:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.